Virtual screening on the web for drug repurposing: a primer
We describe a procedure of performing in silico (virtual) screening using a web-based service, the MTiOpenScreen, which
is freely accessible to non-commercial users. We shall use the SARS-CoV-2 main protease as an example. Starting from a structure downloaded from the Protein Data Bank, we discuss how to prepare the coordinates file, taking into account the known biochemical background information of the target protein. The reader will find that this preparation step takes up most of the effort before the target is ready for screening. The steps for uploading the target structure and defining the search volume by critical residues, and the main parameters to use, are outlined. When this protocol is followed, the user will expect to obtain a ranked list of small approved drug compounds docked into the target structure. The results can be readily examined graphically on the web site or downloaded for studying in a local molecular graphics program such as PyMOL.
Chen YW, Yiu CB, Wong K. (2020) Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Res 9: 129. doi: 10.12688/f1000research.22457.2. PMID: 32194944
Labbé CM, Rey J, Lagorce D, Vavruša M, Becot J, et al. (2015) MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res 43: doi: 10.1093/nar/gkv306. PMID: 25855812
Lagarde N, Rey J, Gyulkhandanyan A, Tufféry P, Miteva MA, et al. (2018) Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets. Oncotarget 9: 32346-32361. doi: 10.18632/oncotarget.25966. PMID: 30190791
The PyMOL molecular graphics system. Schrödinger LLC. Version 1.7 or later. Available from: https://pymolwiki.org/index.php/Linux_Install
Emsley P, Lohkamp B, Scott WG, Cowtan K. (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501. doi: 10.1107/S0907444910007493. PMID: 20383002
Trott O, Olson AJ. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461. doi: 10.1002/jcc.21334. PMID: 19499576
Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, et al. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67: 235-242. doi: 10.1107/S0907444910045749. PMID: 21460441
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242. doi: 10.1093/nar/28.1.235. PMID: 10592235
Muramatsu T, Takemoto C, Kim Y, Wang H, Nishii W, et al. (2016) SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity. Proc Natl Acad Sci U S A 113: 12997-13002. doi: 10.1073/pnas.1601327113. PMID: 27799534
Jaghoori MM, Bleijlevens B, Olabarriaga SD. (2016) 1001 Ways to run AutoDock Vina for virtual screening. J Comput Aided Mol Des 30: 237-249. doi: 10.1007/s10822-016-9900-9. PMID: 26897747
Quiroga R, Villarreal MA. (2016) Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening. PLoS One 11: doi: 10.1371/journal.pone.0155183. PMID: 27171006
Singh N, Decroly E, Khatib A, Villoutreix BO. (2020) Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages. Eur J Pharm Sci 153: 105495. doi: 10.1016/j.ejps.2020.105495. PMID: 32730844
Yang H, Yang M, Ding Y, Liu Y, Lou Z, et al. (2003) The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA 100: 13190-13195. doi: 10.1073/pnas.1835675100. PMID: 14585926
Jin Z, Du X, Xu Y, Deng Y, Liu M, et al. (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582: 289-293. doi: 10.1038/s41586-020-2223-y. PMID: 32272481
Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, et al. (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583: 459-468. doi: 10.1038/s41586-020-2286-9. PMID: 32353859
How to Cite
Copyright (c) 2021 Yu Wai Chen, Chin-Pang Bennu Yiu, Kwok-Yin Wong
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with JBM agree to the following terms:
- Authors retain copyright and grant JBM right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).